Dendrite Announces Record Time Rollout With Takeda; Japan's Largest Pharmaceutical Company Implements Sales Force Effectiveness Solution for 2,000 Users in 7 Months.

MORRISTOWN, N.J.--(BUSINESS WIRE)--August 24, 1998--Dendrite International, Inc. (NASDAQ/NMS:DRTE), today announced the highly successful rollout of 2,000 users at Takeda Chemical Industries Ltd. last month. This rollout including customization, pilot and full user training was fully completed within 7 months of the signing. This is recognized to be both a Japanese and world record implementation time for a sales force of this size.

"Our implementation schedule was shortened as a result of adopting the high-quality Dendrite system, which meets the Japanese market needs", said Mr. Yoshinori Sato, General Manager of Information, Systems Department of Takeda. "Such short implementation period was made possible due to the teamwork between Dendrite Japan and Takeda working towards a common goal." Added Mr. Koisuke Izumi, Manager of 2nd Systems Development Group.

Commenting on the successful rollout, John Bailye, President and CEO of Dendrite said, "We are delighted to be a contributor to Takeda's ongoing success. This new benchmark of success reinforces the importance of our in-depth understanding of the Japanese pharmaceutical industry coupled with our infrastructure of staff and skills." Mr. Bailye added, "We are committed to the overall outcome of the effort as opposed to just the system components, reflecting our mission of providing risk free and cost effective SFA solutions to the pharmaceutical industry worldwide."

About Dendrite

Leading supplier of enterprise-wide sales force effectiveness solutions for the pharmaceutical and Consumer Packaged Goods (CPG) industries. Over 40,000 sales representatives and their managers in over 150 major corporations in 17 countries rely on Dendrite for a uniquely tailored combination of tools, information and skills to help them adapt to change and improve their sales success. The Company uses its highly specialized industry knowledge to develop modular software products that enhance sales force effectiveness by leveraging massive amounts of data to create actionable information, direct sales activities and facilitate enterprise-wide communication. The products, combined with specifically tailored coaching and support services, focus sales representatives on improving their performance. With a global infrastructure as its foundation, Dendrite's commitment to unparalleled service has been the hallmark of the business and the basis of strong customer loyalty since the Company's inception.

Dendrite has two major divisions: the Healthcare Division, which is the largest supplier of sales force effectiveness solutions to the global pharmaceutical industry; and the Consumer Business Division, which serves the over-the-counter drug, cosmetics and consumer packaged goods industries worldwide.

Headquartered in Morristown, New Jersey, Dendrite employs over 650 people in 14 offices around the world. For more information, visit the Company's Web site: http://www.drte.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

This press release may contain statements that, if they are not verifiable historical fact, may be viewed as forward-looking statements that could predict future events or outcomes with respect to Dendrite and its business. The predictions embodied in these statements will involve risks and uncertainties and, accordingly, Dendrite's actual results may differ significantly from the results discussed or implied in such forward-looking statements.

For more information, contact John E. Bailye, CEO, or George Robson, CFO, Dendrite International, Inc., 1200 Mt. Kemble Ave., Morristown, NJ 07960; Telephone: [phone].

    CONTACT:  Dendrite International, Morristown
               John Bailye, CEO
               George Robson, CFO
               973-425-1200